Thomas Moritz

Tightly regulated ‘all-in-one’ lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy

T. Moritz, B. Schiedlmeier, C. Baum, 2015, Gene Therapy.

Deoxycytidine-kinase knockdown as a novel myeloprotective strategy in the context of fludarabine, cytarabine or cladribine therapy

M. Heuser, T. Moritz, V. Kaever, 2015, Leukemia.

MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy

A. Schambach, T. Cantz, D. Heckl, 2011, Gene Therapy.

CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells

A. Schambach, C. Mussolino, N. Lachmann, 2024, International journal of molecular sciences.

A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny

A. Schambach, T. Cantz, H. Niemann, 2013, Stem cells.